SANGAMO THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price

SANGAMO THERAPEUTICS, INC. (SGMOQ) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price of $10.02 per share as of 2020-12-31, per its 10-K filed 2021-02-24.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice · last filed 2021-02-24

2020-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $10.02.
2019-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $10.71.
2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $11.23.
2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $7.77.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
2020-12-31	$10.02 10-K · filed 2021-02-24
2019-12-31	$10.71 10-K · filed 2020-02-28
2018-12-31	$11.23 10-K · filed 2019-03-01
2017-12-31	$7.77 10-K · filed 2018-03-01
2016-12-31	$8.39 10-K · filed 2017-02-28
2015-12-31	$9.15 10-K · filed 2016-02-18
2014-12-31	$8.67 10-K · filed 2015-02-25
2013-12-31	$7.10 10-K · filed 2014-02-24
2012-12-31	$6.25 10-K · filed 2013-02-26